RESUMO
BACKGROUND: Seizure prediction can increase independence and allow preventative treatment for patients with epilepsy. We present a proof-of-concept for a seizure prediction system that is accurate, fully automated, patient-specific, and tunable to an individual's needs. METHODS: Intracranial electroencephalography (iEEG) data of ten patients obtained from a seizure advisory system were analyzed as part of a pseudoprospective seizure prediction study. First, a deep learning classifier was trained to distinguish between preictal and interictal signals. Second, classifier performance was tested on held-out iEEG data from all patients and benchmarked against the performance of a random predictor. Third, the prediction system was tuned so sensitivity or time in warning could be prioritized by the patient. Finally, a demonstration of the feasibility of deployment of the prediction system onto an ultra-low power neuromorphic chip for autonomous operation on a wearable device is provided. RESULTS: The prediction system achieved mean sensitivity of 69% and mean time in warning of 27%, significantly surpassing an equivalent random predictor for all patients by 42%. CONCLUSION: This study demonstrates that deep learning in combination with neuromorphic hardware can provide the basis for a wearable, real-time, always-on, patient-specific seizure warning system with low power consumption and reliable long-term performance.
Assuntos
Epilepsia/diagnóstico , Aprendizado de Máquina , Convulsões/diagnóstico , Estatística como Assunto , Benchmarking , Humanos , Fatores de TempoRESUMO
Brain-computer interfaces are commonly proposed to assist individuals with locked-in syndrome to interact with the world around them. In this paper, we present a pipeline to move from recorded brain signals to real-time classification on a low-power platform, such as IBM's TrueNorth Neurosynaptic System. Our results on a EEG-based hand squeeze task show that using a convolutional neural network and a time preserving signal representation strategy provides a good balance between high accuracy and feasibility in a real-time application. This pathway can be adapted to the management of a variety of conditions, including spinal cord injury, epilepsy and Parkinson's disease.